NH1,902.90

Narayana Hrudayalaya Ltd.

· Pharma & Health
₹ CrorePeersAPOLLOHOSPMAXHEALTHFORTISNEULANDLABNATCOPHARMLALPATHLABSAILIFECOHANCEMcap ₹38,888 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation242.1278.1449.5
+ Finance Costs96.9146.4243.7
+ Interest Income-17.4-20.7-39.7
+ Unrealised FX (Gain) / Loss11.112.2-26.5
+ Other Non-cash Items-47.2-16.8-20.4
+ Other — Cash Effects are Investing / Financing-0.8-10.1-10.5
+ Other Reconciling Items0.0-8.24.6
Changes in Working Capital
+ Inventories-38.4-0.3-24.9
+ Trade Receivables — Current26.4-149.021.2
+ Other Financial Assets — Current15.9-6.0-267.5
+ Other Financial Assets — Non-current-8.1-100.8-11.5
+ Other Current Assets255.6-186.0231.8
+ Other Non-current Assets-260.9252.1-49.8
+ Trade Payables — Current-11.5-29.1457.7
+ Other Financial Liabilities — Current-7.037.165.6
+ Other Financial Liabilities — Non-current-13.3-16.31.5
+ Other Current Liabilities16.3-23.2-277.1
+ Other Non-current Liabilities4.311.0-7.2
+ Provisions — Current6.13.033.1
+ Provisions — Non-current-0.97.326.5
Cash from Operating Activities
Profit Before Tax (per I/S)888.5935.5974.41,005.4
+ Total Adjustments (incl. Working Capital)269.3180.8799.9
Cash from Operations (pre-tax)1,157.81,116.41,774.3
+ Income Taxes Paid91.2126.3155.8
Cash from Operating Activities1,066.6990.11,618.5
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)970.61,073.8874.9
+ Disp of Fixed Assets3.13.06.7
+ Acq of Subsidiaries / Businesses (net)0.00.02,154.5
+ Interest Received — Investing18.116.419.0
+ Other Inflows / (Outflows) — Investing-508.5-262.8-649.5
Cash from Investing Activities-1,457.9-1,317.1-3,653.2
Cash from Financing Activities
+ Proceeds from Exercise of Stock Options0.00.00.0
+ Proceeds from Debentures / Notes / Bonds300.1500.00.0
+ Proceeds from Borrowings522.7504.92,946.1
+ Repayment of Borrowings154.5223.2217.3
+ Payment of Lease Liabilities56.252.6128.2
+ Interest Paid72.9116.0166.7
+ Dividends Paid50.881.291.0
Cash from Financing Activities488.5531.82,342.9
Net Changes in Cash (pre-FX)97.1204.8308.2
+ Effect of FX Rate Changes on Cash0.00.75.2
Net Changes in Cash97.1205.4313.4
Closing Cash241.7760.6
Reference Items
EBITDA1,152.41,276.41,616.71,749.4
EBITDA Margin %22.9623.2820.4719.28
Free Cash Flow (CFO − Capex)96.0-83.7743.5743.5
Free Cash Flow to Equity569.93,229.5
Free Cash Flow per Basic Share4.70-4.0936.3836.38
Price to Free Cash Flow52.30
Cash Flow to Net Income1.351.252.01
Cash Paid for Taxes91.2126.3155.8
Cash Paid for Interest72.9116.0166.7
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.